1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Veterinary Vaccines Market?
The projected CAGR is approximately 6.5%.
+1 2315155523
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
U.S. Veterinary Vaccines MarketU.S. Veterinary Vaccines Market by Product (Inactivated, Live Attenuated, Recombinant, Others), by Animal (Companion, Livestock), by Route of Administration (Oral, Parenteral, Others), by Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others), by Forecast 2026-2034
The U.S. Veterinary Vaccines Market size was valued at USD 4.12 USD Billion in 2023 and is projected to reach USD 6.40 USD Billion by 2032, exhibiting a CAGR of 6.5 % during the forecast period. The vaccine is a biological preparation, that provokes an immune response in an animal that would enable it to develop immunity for specific diseases. There are large and diverse numbers of vaccines available, for example, there are live attenuated, inactivated, recombinant, and DNA vaccines. The vaccines create a desirable situation where these elements can be manifested under safety, efficacy, and duration of protection. Applications of such an approach may include stopping contagious diseases (viruses, parasites, etc) in farm animals, pets, and wildlife, and making a safer environment for all of us. In the US we find an increasing interest of consumers in these new-generation vaccines, individualized vaccines, and vaccines against rapidly increasing pathogens. More importantly, the focus is on improving vaccine accessibility, affordability, and sustainability to meet various animal health challenges. The latter does not necessarily mean the end of the world.
The U.S. veterinary vaccines market is segmented by product, animal, route of administration, and distribution channel.
By Product
By Animal
By Route of Administration
By Distribution Channel
The U.S. veterinary vaccines market report provides a comprehensive analysis of the market, including:
The U.S. veterinary vaccines market is primarily driven by the companion animal segment. The increasing adoption of pets in the U.S. is the key factor driving the growth of this segment. The livestock segment is also expected to grow at a steady pace, driven by the growing demand for meat and poultry products.
The pricing of veterinary vaccines varies depending on the product, animal, and route of administration. Inactivated vaccines are generally less expensive than live attenuated vaccines. Recombinant vaccines are the most expensive type of vaccine.
The U.S. is a net exporter of veterinary vaccines. The major export markets for U.S. veterinary vaccines include Canada, Mexico, and the European Union. The U.S. also imports veterinary vaccines from other countries, such as China and India.
The U.S. Patent and Trademark Office (USPTO) has granted several patents related to veterinary vaccines. These patents cover a wide range of topics, including new vaccine technologies, vaccine formulations, and methods of use.
Some of the most recent patents granted by the USPTO include:
These patents are a valuable asset for companies developing and manufacturing veterinary vaccines. They provide exclusive rights to the patented technology, which can give companies a competitive advantage in the market.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.5% from 2020-2034 |
| Segmentation |
|
Note*: In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 6.5%.
Key companies in the market include Elanco (U.S.), HIPRA (Spain), Boehringer Ingelheim International GmbH (Germany), Virbac (France), MSD Animal Health (U.S.), Zoetis (U.S), Ceva (France), NEOGEN CORPORATION (U.S.), Hester Biosciences Limited (India).
The market segments include Product, Animal, Route of Administration, Distribution Channel.
The market size is estimated to be USD 4.12 USD Billion as of 2022.
Introduction of Cost-effective Manufacturing Processes to Drive Market Growth.
Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
Growing Distress Over Vaccine Failure May Hamper Market Growth.
February 2023 – Mazen Animal Health received patent from the U.S. Patent and Trademark Office (USPTO) for its maize-based vaccines against porcine epidemic diarrhea virus (PEDV).
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.
The market size is provided in terms of value, measured in USD Billion and volume, measured in No.of doses.
Yes, the market keyword associated with the report is "U.S. Veterinary Vaccines Market," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the U.S. Veterinary Vaccines Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.